In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

Research output: Contribution to journalArticle

Colleges, School and Institutes

Details

Original languageEnglish
Pages (from-to)e1-e3
JournalBiochemical Pharmacology
Volume75
Issue number6
Publication statusPublished - 15 Mar 2008